According to authoritative data, in 2024, there were 589 million adults worldwide with diabetes, and this number is projected to exceed 1.31 billion by 2050. How to achieve more precise and convenient blood glucose management has become a key focus for the healthcare industry. Against this backdrop, Continuous Glucose Monitoring (CGM), as an emerging technology in diabetes management, is reshaping patient care models with its advantages of real-time and accurate monitoring, offering new solutions for clinical diagnosis and daily health management.
Figure 1: Continuous Glucose Monitor (CGM) Usage Scenario
Focusing further on core technical challenges: how to balance the need for prolonged battery life and reliable real-time data transmission while ensuring accurate and timely feedback of monitoring data, all based on a miniaturized device design. These three major issues have become the core bottlenecks for the CGM industry's development and are crucial directions for technological R&D and product innovation.
Awinic, a leading Chinese analog and mixed-signal IC company, has established a comprehensive portfolio of magnetic sensor products with its core Hyper-Hall™ technology. To clarify the technical roadmap, precisely cover different market segments, and help customers quickly identify product features and perceive core technological value, Awinic has subdivided the Hyper-Hall™ into three product series:
S Series (Steady): Focuses on stability and reliability, meeting scenarios with basic requirements.
R Series (Rugged): Emphasizes ruggedness and durability, suitable for complex operating conditions requiring high reliability.
X Series (X-accelerate): Pursues extreme performance and breakthrough technology, empowering high-end scenarios with leading product experience and technical specifications.
As a member of the Hyper-Hall™ X Series Hall sensor family, the AW86501BDC sets industry benchmarks with several core technological advantages:
It achieves an industry-leading ultra-low power consumption, with an operating current of only 50nA, comparable to TMR-level products, laying a key foundation for enhancing device battery life.
It utilizes an ultra-small 1×1mm package, significantly saving PCB space and meeting the miniaturization design needs of CGM products.
It features built-in external stray magnetic field suppression, effectively resisting environmental interference and ensuring high reliability of data transmission.
The AW86501BDC Hall sensor addresses the three core pain points of "space constraints, battery life anxiety, and environmental interference," providing fundamental enablement through "miniaturized space adaptation, long shelf-life assurance, and high-stability performance support."
Ultra-Low Operating Voltage, Ultra-Low Power Consumption
Wide voltage input: 1.2V-3.6V (supports power supply from 1.5V SR series & 3V CR series button batteries)
Utilizes NPC technology to achieve an ultra-low 50nA operating current, extending CGM shelf life up to 2 years.
Breaks power consumption limits, features wide voltage input, leading the industry in battery life capability.
Figure 2: Power Consumption Comparison
Ultra-Small Package Enhances Device Miniaturization
Dimensions: 1*1*0.4 (max) mm, minimizing installation space and enhancing the unobtrusive wear experience of CGMs.
The Hyper-Hall™ series reduces package area by approximately 90% compared to traditional series.
Figure 3: Package Area Comparison
Strong Anti-Interference, Superior Reliability
Supports Latch function, with a drive capability of up to 20mA.
Resists external stray magnetic field interference, ensuring more reliable real-time blood glucose data transmission.
Figure 4: Strong Anti-Interference Output Comparison Chart
沪ICP备10011954号 |
沪公网安备 31011202011955号
EN